Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at three years

BACKGROUND: Alzheimer’s disease (AD) is the most common dementing illness. Development of effective treatments directed at AD requires an early diagnosis. Mild cognitive impairment (MCI) often heralds AD. Thus, characterizing MCI is fundamental to the early diagnosis of AD. PARTICIPANTS: Nineteen MC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pardo, José V., Lee, Joel T., Kuskowski, Michael A., Munch, Kristin R., Carlis, John V., Sheikh, Sohail A., Surerus, Christa, Lewis, Scott M., McCarten, J. Riley, Fink, Howard, McPherson, Susan, Shah, Hemant H., Rottunda, Susan, Dysken, Maurice W.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2918397/
https://ncbi.nlm.nih.gov/pubmed/20447873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2009.09.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars